Innocan Pharma hires Lytham Partners to lead investor relations and shareholder communications program

Herzliya, Israel and Calgary, Alberta – (Newsfile Corp. – May 10, 2021) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) announced today hui he retained the services of Lytham Partners, LLC (“Lytham Partners”) to lead an investor relations and shareholder communications program. For over …

Read More »